TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03399461

Intervention type: OTHER
Intervention: Patient Interview guide
Description: The interviewer will conduct the interview for subjects with WAS using a semi-structured patient interview guide.

Intervention type: OTHER
Intervention: Caregiver interview guide
Description: The interviewer will conduct the interview for caregivers of subjects with WAS using a semi-structured caregiver interview guide.

Intervention type: OTHER
Intervention: Caregiver interview guide
Description: The interviewer will conduct the interview for caregivers of subjects with WAS using a semi-structured caregiver interview guide.

Intervention type: OTHER
Intervention: Sociodemographic questionnaire
Description: At the end of interview, subjects will be required to complete subject or caregiver versions of country-specific sociodemographic questionnaire.

Intervention type: OTHER
Intervention: Sociodemographic questionnaire
Description: At the end of interview, subjects will be required to complete subject or caregiver versions of country-specific sociodemographic questionnaire.
Study: NCT02406261

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: 250 mcg midazolam will be administered intravenous (IV) as 0.25 mL of 1-mg/mL injection solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil
Description: 5 mg donepezil will be administered orally as 1 × 5-mg tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lanabecestat
Description: 50 mg lanabecestat will be administered orally as 1 × 50-mg tablet
Study: NCT03016117

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pecs II block and parasternal block
Description: The Pecs II block will be performed under ultrasound guidance, at fourth rib level, on the axillary line, into the fascial plane between pectoralis minor muscle and serratus muscle. The parasternal block will be performed under ultrasound guidance, at the second and fourth intercostal space, between the pectoralis major muscle and the intercostal muscles, near to the external intercostal membrane.
Study: NCT03753711

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multifidus muscle biopsy during minimally invasive back surgery
Description: Bilateral biopsy of the multifidus muscle in patient with a unilateral disc hernia.
Study: NCT04892056

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Frictionless Mechanics
Description: anterior segment retraction using closing loops
Study: NCT03993899

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: FineHearing strategy or HDCIS strategy
Description: Cochlear implant with FineHearing strategy or HDCIS strategy
Study: NCT03399461

Intervention type: OTHER
Intervention: Sociodemographic questionnaire
Description: At the end of interview, subjects will be required to complete subject or caregiver versions of country-specific sociodemographic questionnaire.

Intervention type: OTHER
Intervention: Pediatric quality of life (PedsQL) questionnaire
Description: The PedsQL is a validated generic measure of health-related quality of life (HRQOL) in children, adolescents, and young adults with acute and chronic health conditions. At the end of interview, subjects will be required to complete subject or caregiver versions of PedsQL questionnaire.

Intervention type: OTHER
Intervention: Pediatric quality of life (PedsQL) questionnaire
Description: The PedsQL is a validated generic measure of health-related quality of life (HRQOL) in children, adolescents, and young adults with acute and chronic health conditions. At the end of interview, subjects will be required to complete subject or caregiver versions of PedsQL questionnaire.
Study: NCT03653260

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine (Zingo)
Description: 0.5 mg lidocaine, 20 bar pressure

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo injector, 20 Bar pressure, empty injector
Study: NCT02381834

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bladder stimulation technique
Study: NCT03360305

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: GAPcare intervention
Description: Subjects will receive PT and pharmacist evaluation. PT will help determine whether subject may benefit from doing exercises to improve strength or balance. PT may also supply subject with an assist device. A pharmacist will ask patient about any medication they are taking and will make recommendations on how their medication could be changed to prevent falls. Pharmacists will communicate this information to subject's doctors. Subjects will receive a fall calendar for home, where they will record any falls they have after their discharge from the ED. They will receive a phone call at home asking about any recent falls and health care interactions. Study personnel will call subjects every 2 weeks for 6 months. Subjects may receive a referral for outpatient or home-based physical and occupational therapy at the end of the visit.
Study: NCT03399461

Intervention type: OTHER
Intervention: Pediatric quality of life (PedsQL) questionnaire
Description: The PedsQL is a validated generic measure of health-related quality of life (HRQOL) in children, adolescents, and young adults with acute and chronic health conditions. At the end of interview, subjects will be required to complete subject or caregiver versions of PedsQL questionnaire.

Intervention type: OTHER
Intervention: Clinical questionnaire
Description: At the end of interview, subjects will be required to complete subject or caregiver versions of clinical questionnaire.
Study: NCT04562103

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinephrine / Ropivacaine
Description: In this group quadratus lomborum block was performed with 0.375% ropivacaine+100 mcg epinephrine.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: In this group quadratus lomborum block was performed with plane 0.375% ropivacaine.
Study: NCT03399461

Intervention type: OTHER
Intervention: Clinical questionnaire
Description: At the end of interview, subjects will be required to complete subject or caregiver versions of clinical questionnaire.

Intervention type: OTHER
Intervention: Clinical questionnaire
Description: At the end of interview, subjects will be required to complete subject or caregiver versions of clinical questionnaire.
Study: NCT03981601

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lovastatin 40 MG
Description: after tooth extraction, put teh lovastatin40 mg wif bone graft wifin tooth socket

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: without drug with Bone graft
Description: after tooth extraction, put teh bone graft wifin tooth socket
Study: NCT03088514

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beetroot juice
Description: Beetroot juice (70ml daily) with or without inorganic nitrate

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Beetroot juice
Description: Beetroot juice (70ml daily) with or without inorganic nitrate

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beetroot juice
Description: Beetroot juice (70ml daily) with or without inorganic nitrate

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Beetroot juice
Description: Beetroot juice (70ml daily) with or without inorganic nitrate
Study: NCT02691000

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LiteBook
Description: Light therapy using a Bright White Light Litebook for 1 hour each morning for 8 weeks. This is the experimental intervention.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: LiteBook
Description: Light therapy using a Dim Red Light Litebook for 1 hour each morning for 8 weeks. This is the control.
Study: NCT06231784

Intervention type: DEVICE
Group type: OTHER
Intervention: LUMINA IOL
Description: A standard technique of phacoemulsification was performed followed by implantation of the Lumina in the sulcus plane of the eye by using a standard disposable injector system with an adapted, proprietary, AkkoLens butterfly cartridge.
Study: NCT02694731

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile application intervention (Device: Smartphone)
Description: Consists of the app described in the arm description.
Study: NCT04567056

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sample
Description: A separate blood sample will be taken for methylation-analyses
Study: NCT01151137

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dronedarone
Description: Film-coated tablet~Oral administration under fed conditions (during breakfast and dinner)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (for Dronedarone)
Description: film-coated tablet strictly identical in appearance~Oral administration under fed conditions (during breakfast and dinner)
Study: NCT02600299

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation group
Description: On the basis of previous studies that evaluated PEG interventions for women with breast cancer, a structured program based on the Cognitive Behavioral Therapy (CBT) principles was developed. Patients in the PEG group will be involved in three sessions of psychoeducation. The PEG program is designed to cover the various aspects outlined by the IOM on quality cancer survivorship.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Usual Care
Description: Usual Care
Study: NCT04409678

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: activity
Description: physical activity
Study: NCT04256928

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Preoperative electrical clipping
Description: Body hair in the operative field will be clipped with an electrical clipper by hospital personnel during preparation to planned surgery.
Study: NCT03604666

Intervention type: OTHER
Intervention: Health care process with Nurse Navigator
Description: A Nurse Navigator will:~* Be present at the announcement consultation~* Give information on the outpatient circuit~* Offer assistance for patients over 75 years~* Complete onco-geriatric orientation questionnaires~* Take care of patients on the ambulatory circuit
Study: NCT00519870

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: nifedipine, losartan
Description: I: nifedipine 30 mg/d II: losartan 50 mg/d

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: losartan
Description: II: losartan

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nifedipine, losartan
Description: I: nifedipine II: losartan
Study: NCT01381081

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: platelet-rich plasma
Description: a single intra-articular injection

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroid
Description: A single betamethasone and bupivacaine intra-articular injection
Study: NCT02656472

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic acid
Description: TXA Loading dose: 31 mg/kg diluted to 2 ml/kg Normal saline (NS) -in syringe

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epsilon Aminocaproic Acid
Description: Aminocaproic acid Loading dose: 75 mg/kg diluted to 2 ml/kg NS
Study: NCT04314505

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Opioid-Sparing Protocol
Description: After a general anesthesia procedure was performed, an experienced anesthesiologist performed ultrasound guided adductor canal block procedures on both knees. In the opioid-sparing group, a dose of Parecoxib sodium 40 mg was administrated through intravenous route before the incision. After the surgery, Parecoxib sodium 40 mg was given intravenously every 12 hours for 4 more doses. Before the wound closure, the periarticular injection (each side 10 ml of 0.25% Bupivacaine) was done. The total dosage would be recorded in the device. All patients received oral paracetamol 500mg, 4 times a day and oral celecoxib 200mg, 2 times a day after surgery.
Study: NCT03626298

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Adapalene
Description: third-generation topical retinoid primarily used in the treatment of mild-moderate acne. It is effective against acne conditions where comedones are predominant.
Study: NCT01947023

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo tumor biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabrafenib
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabrafenib Mesylate
Description: Given PO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lapatinib
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lapatinib Ditosylate
Description: Given PO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET
Study: NCT01559909

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vacuum assisted socket technology (Harmony System, Otto Bock Healthcare)
Description: The brim height of the socket will be systematically reduced
Study: NCT01938157

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Diffusion-weighted MR imaging
Description: An addition 90 seconds of DWI will be added to a clinical breast MRI for all patients agreeing to participate in the study.
Study: NCT04265066

Intervention type: DIAGNOSTIC_TEST
Intervention: microcirculation
Description: measurement of microcirculation
Study: NCT02583984

Intervention type: PROCEDURE
Intervention: Thoracic Surgery with Lung Resection
Description: General anesthesia and lung separation Thoracic surgery with lung resection, such as lobectomy, segmentectomy

Intervention type: PROCEDURE
Intervention: Thoracic Surgery without Lung Resection
Description: General anesthesia and lung separation Thoracic surgery without lung resection, such as esophageal surgery, mediastinal surgery
Study: NCT04617808

Intervention type: OTHER
Intervention: Questionnaire
Description: The regulatory scheme applied to all investigative centers is as follows:~* Call from Center 15 by a major patient for secondary headache no traumatic. (i.e. not having been the victim of a head trauma during the 48 hours preceding the call)~* Detection of the pattern of non-traumatic headache, by the regulatory assistant medical with registration of the word cephareg in the medical regulation software in order to alert the regulator about the possible inclusion of the patient~* If possible, patient information on the collection of their data for research and possibility of opposing~* Filling of a medical questionnaire by the regulating doctor~* Weekly collection of medical questionnaires by investigating doctors
Study: NCT04644848

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasonographical tattooing of suspicious axillary lymph nodes.
Description: Patients with clinically negative axillae scheduled for sentinel lymph node biopsy (SLNB) will have axillary ultrasonographical imaging of the ipsilateral axilla with a high-frequency linear probe. Suspicious lymph nodes are identified according to any of the following criteria:~* Round shape.~* Cortical thickness \> 3 mm~* Eccentric cortical thickness.~* Loss of hilum.~For each patient, node dimensions and the presence of each of the above-mentioned criteria are recorded. Tattooing of all suspicious nodes is done using I ml of sterile liquid charcoal.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy
Description: Sentinel node biopsy is performed with peri-areolar subdermal injection of 3 ml methylene blue 5%. The lymphatics are tracked to the first blue lymph node. All blue, enlarged and /or tattooed nodes are separately biopsied and labelled as SLN and/or tattooed node.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Histopathological examination of the axillary nodes
Description: All tattooed nodes are excised and sent to frozen section examination; labelled tattoo node.~All enlarged or blue stained nodes are excised and sent to frozen section examination; labelled sentinel node.~All nodes are bisected and a single 5 um section examined. All frozen section examinations are followed by routine paraffin section examination.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Further axillary management
Description: Further axillary management is performed as per institutional guidelines. If SLNB is negative, no further surgery is required. Axillary lymph node dissection is performed if sentinel lymph node is positive or not identified. Management of positive SLNB as per the American College Of Surgeons' Oncology Group (ACOSOG) Z0011 protocol is not currently adopted on routine basis at the investigators' institution. In this study, patients with tattooed nodes with positive histopathological findings are offered full axillary dissection even if their sentinel nodes are negative.
Study: NCT00880750

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate Granule Formulation
Description: 3x's per day for 3 days, 1 dose in the am for day 4. (A single dose equals 1000mg of lanthanum carbonate granule formulation. Dose is administered immediately after each meal.)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate Chewable Tablets (Fosrenol)
Description: 3x's per day for 3 days, 1 dose on day 4. (A single dose equals a 1000mg tablet of lanthanum carbonate. Dose is administered immediately after each meal.)
Study: NCT01224548

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: vegan instruction and food accessibility
Description: weekly 1-hr instructions including vegan nutritional information and cooking instructions. vegan menu will be made available at the cafeteria

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: control
Description: no intervention in until June 2011. The control group start vegan diet in July 2011.
Study: NCT04025632

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: zilucoplan
Description: Daily subcutaneous (SC) inection

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily subcutaneous (SC) inection
Study: NCT03688386

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reading intervention
Description: Written packet with 3 lessons. The first lesson includes how to begin to read and talk to their baby. The second lesson includes reading or talking about the day using parentese talk. The third lesson includes continuing to engage with the baby through interactive reading.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Infant bonding
Description: Written packet with 3 lessons. The first lesson includes skin-to-skin and learning about their baby. The second lesson includes learning readiness cues and participation in feeding times. The third lesson includes developing routines and playing games.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Infant bonding
Description: Written packet with 3 lessons. The first lesson includes skin-to-skin and learning about their baby. The second lesson includes learning readiness cues and participation in feeding times. The third lesson includes developing routines and playing games.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: LENA recording
Description: The LENA device provide 16 hours of language recordings placed inside an infant vest. The recordings are uploaded to a computer which analyzes total adult word counts, infant vocalizations, conversational turns, background noise, and silence.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LENA recording
Description: The LENA device provide 16 hours of language recordings placed inside an infant vest. The recordings are uploaded to a computer which analyzes total adult word counts, infant vocalizations, conversational turns, background noise, and silence.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LENA linguistic feedback
Description: LENA recordings of adult word counts, infant vocalizations, and conversational turns will be provided in printed form after each recording with review of each recording and progress over time.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: LENA summary
Description: All 3 LENA recording summaries of adult word counts, infant vocalizations, and conversational turns will be summarized in printed form and provided to mother at discharge.
Study: NCT03990129

Intervention type: DRUG
Group type: OTHER
Intervention: Metamizole
Description: One week treatment with metamizole (500 mg tablets, 2-2-2)
Study: NCT02610309

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family-Based Crisis Intervention
Description: This intensive ED-based intervention with suicidal adolescents and their families includes cognitive behavioral skill building, psychoeducation, enhancing therapeutic readiness, safety planning, and co-creation of a joint crisis narrative.
Study: NCT03626298

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adapalene
Description: third-generation topical retinoid primarily used in the treatment of mild-moderate acne. It is effective against acne conditions where comedones are predominant.
Study: NCT04314505

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Opioid-Based Patient Controlled Analgesia
Description: After a general anesthesia procedure was performed, an experienced anesthesiologist performed ultrasound guided adductor canal block procedures on both knees. The patient was informed that the intravenous bolus of rescue morphine (4mg) was available every 4 hours if the pain was intolerable. In the PCA group, the device was applied before incision and the initial setting was 0.01mg/kg\*hour, patient-controlled dose 2 mg, lock-out 5 minutes and limited 40mg in each 4 hours. After the surgery, the staff of PCA group would visit the patients and adjusted the dosage. The PCA was removed after 72 hours from the surgery. Before the wound closure, the periarticular injection (each side 10 ml of 0.25% Bupivacaine) was done. The total dosage would be recorded in the device. All patients received oral paracetamol 500mg, 4 times a day and oral celecoxib 200mg, 2 times a day after surgery.
Study: NCT01337349

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sugar Pill 400mg taken orally three times a day for 6 months

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Description: Pentoxifylline 400mg taken orally Three times a day for 6 months
Study: NCT04924127

Intervention type: DIAGNOSTIC_TEST
Intervention: Detection of IDH and TERT mutation
Description: Detection of IDH and TERT mutation using frozen glioma tissues

Intervention type: DIAGNOSTIC_TEST
Intervention: Detection of IDH and TERT mutation
Description: Detection of IDH and TERT mutation using frozen glioma tissues